Until 31.12.2024: Save 30% on your first order with code: eversyn30
CMP-C9-azido-Sialic Acid (ammonium salt)
From
€264.00
Synonyms: Cytidine-5'-monophospho-N-acetyl-9-azido-9-deoxy-neuraminic acid; CMP-N-acetyl-9-azidoneuraminic acid; CMP-Neu5Ac9Az; CMP-C9AzNeu5Ac; CMP-9Az-Neu5Ac; CMP-9´-Az-Neu5Ac, CMP-Neu5Ac9N3 (ammonium salt)
CAS No.: N/A
Related CAS No: 112037-53-3 (free acid)
Formula: C20H29N7O15PNH4
Molecular weight: 656.51 g/mol
Quantity
Technical Product Information
|
Other identifiers |
Canonical SMILES: Isomeric SMILES: O(P(OC[C@H]1O[C@H]([C@H](O)[C@@H]1O)N2C(=O)N=C(N)C=C2)(=O)O)[C@]3(C(O)=O)O[C@@]([C@@H]([C@@H](CN=[N+]=[N-])O)O)([C@H](NC(C)=O)[C@@H](O)C3)[H] InChI Key: YZOBTNNKILRMMB-BILDWYJOSA-N |
|
Description |
CMP-Neu5Ac9N3 is an advanced sialic acid nucleotide sugar analog featuring an azide group at the C9 position. The product is designed for research use in bioorthogonal, click-chemistry-based glycoengineering, and selective labeling of glycans. Key features:
The product is for research use only, not for use in diagnostic procedures. |
|
Appearance |
Lyophilized white powder |
|
Purity |
≥ 95% (HPLC-UV). Product has not been tested for endotoxins. |
|
Storage |
At -20°C. |
Applications (Research Use Only)
Biotherapeutics & Drug Conjugation
-
Development of site-specific antibody-drug conjugate (ADC), peptide-drug conjugate (PDC), and glycoconjugate vaccine via selective glycan remodeling, enabling homogeneous drug attachment and optimized pharmacokinetics
-
Generation of novel bioconjugates including labeled antibodies, engineered glycoproteins, or functionalized exosomes for targeted delivery or imaging studies.
Cellular and Molecular Biology
-
Live cell glycan labeling for imaging, proteomics, and flow cytometry using click chemistry with alkyne-modified probes.
-
Mechanistic studies of glycosylation, glycan-protein interactions including Siglecs (Sialic acid-binding Immunoglobulin-like Lectins), and cell-surface glycan mapping.
Antimicrobial Prophylaxis
-
Investigational use as a topical agent for reducing pathogenic colonization (e.g., N. gonorrhoeae), with efficacy shown in preclinical mouse models.
Analytical Research
-
Exo-enzymatic glycan engineering of exosomes and nanoparticles for functionalization and delivery research.
-
Sialoglycan spin labeling for structural biology and electron paramagnetic resonance (EPR) spectroscopy studies.
All applications listed above are intended exclusively for research use only and are not for use in diagnostic procedures.
Downloads
References
1. Thames, A. H.; Moons, S. J.; Wong, D. A.; Boltje, T. J.; Bochner, B. S.; Jewett, M. C., GlycoCAP: A Cell-Free, Bacterial Glycosylation Platform for Building Clickable Azido-Sialoglycoproteins. ACS Synth Biol 2023, 12 (4), 1264-1274.
2. Yang, G.-Y.; Li, C.; Fischer, M.; Cairo, C. W.; Feng, Y.; Withers, S. G., A FRET Probe for Cell-Based Imaging of Ganglioside-Processing Enzyme Activity and High-Throughput Screening. Angew Chem Int Ed 2015, 54 (18), 5389-5393.
3. Mbua, N. E.; Li, X.; Flanagan-Steet, H. R.; Meng, L.; Aoki, K.; Moremen, K. W.; Wolfert, M. A.; Steet, R.; Boons, G.-J., Selective Exo-Enzymatic Labeling of N-Glycans on the Surface of Living Cells by Recombinant ST6Gal I. Angew Chem Int Ed 2013, 52 (49), 13012-13015.
4. Hosoguchi, K.; Maeda, T.; Furukawa, J.; Shinohara, Y.; Hinou, H.; Sekiguchi, M.; Togame, H.; Takemoto, H.; Kondo, H.; Nishimura, S., An efficient approach to the discovery of potent inhibitors against glycosyltransferases. J Med Chem 2010, 53 (15), 5607-19.
For larger quantities or higher purity
Get in touch with us at info@eversyn.de for more details.























